Literature DB >> 30997527

Statement and supplementary statement from the BVA, the DOG, and the RG on laser treatment of drusen in age-related macular degeneration (AMD) : August 2017, update October 2018.

.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 30997527     DOI： 10.1007/s00347-019-0889-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  41 in total

1.  Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage.

Authors:  A I Jobling; R H Guymer; K A Vessey; U Greferath; S A Mills; K H Brassington; C D Luu; K Z Aung; L Trogrlic; M Plunkett; E L Fletcher
Journal:  FASEB J       Date:  2014-11-12       Impact factor: 5.191

2.  [Basic principles and clinical application of retinal laser therapy].

Authors:  C Framme; J Roider; R Brinkmann; R Birngruber; V-P Gabel
Journal:  Klin Monbl Augenheilkd       Date:  2008-04       Impact factor: 0.700

3.  Treatment of drusen-related aging macular degeneration by photocoagulation.

Authors:  P C Wetzig
Journal:  Trans Am Ophthalmol Soc       Date:  1988

4.  Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.

Authors:  R J Olk; T R Friberg; K L Stickney; L Akduman; K L Wong; M C Chen; M H Levy; C A Garcia; L S Morse
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

5.  Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen.

Authors:  Francesca Mojana; Manpreet Brar; Lingyun Cheng; Dirk-Uwe G Bartsch; William R Freeman
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

Review 6.  [Selective retina therapy: methods, technique, and online dosimetry].

Authors:  R Brinkmann; G Schüle; J Neumann; C Framme; E Pörksen; H Elsner; D Theisen-Kunde; J Roider; R Birngruber
Journal:  Ophthalmologe       Date:  2006-10       Impact factor: 1.059

7.  Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study.

Authors:  C Framme; R Brinkmann; R Birngruber; J Roider
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

8.  Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.

Authors:  Thomas R Friberg; David C Musch; Jennifer I Lim; Larry Morse; William Freeman; Steven Sinclair
Journal:  Ophthalmology       Date:  2006-04       Impact factor: 12.079

9.  Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications.

Authors:  C Frennesson; S E Nilsson
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

10.  Argon laser vs. subthreshold infrared (810-nm) diode laser macular grid photocoagulation in nonexudative age-related macular degeneration.

Authors:  Lucia Scorolli; Daniele Corazza; Mariachiara Morara; Sabrina Vismara; Maria Luisa Lugaresi; Renato Alberto Meduri
Journal:  Can J Ophthalmol       Date:  2003-10       Impact factor: 1.882
View more
  1 in total

Review 1.  The Diagnosis and Treatment of Age-Related Macular Degeneration.

Authors:  Andreas Stahl
Journal:  Dtsch Arztebl Int       Date:  2020-07-20       Impact factor: 5.594
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.